Baxter InternationalBAXEarnings & Financial Report
Baxter International Inc. is an American multinational healthcare company with headquarters in Deerfield, Illinois.
BAX Q4 2025 Key Financial Metrics
Revenue
$3.0B
Gross Profit
$577.0M
Operating Profit
$-729.0M
Net Profit
$-1.1B
Gross Margin
19.4%
Operating Margin
-24.5%
Net Margin
-37.9%
YoY Growth
8.0%
EPS
$-2.21
Financial Flow
Baxter International Q4 2025 Financial Summary
Baxter International reported revenue of $3.0B for Q4 2025, with a net profit of $-1.1B (-37.9% margin). Cost of goods sold was $2.4B, operating expenses totaled $1.3B.
Key Financial Metrics
| Total Revenue | $3.0B |
|---|---|
| Net Profit | $-1.1B |
| Gross Margin | 19.4% |
| Operating Margin | -24.5% |
| Report Period | Q4 2025 |
Baxter International Annual Revenue by Year
Baxter International annual revenue history includes year-by-year totals (for example, 2025 revenue was $11.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $11.2B |
| 2024 | $12.9B |
| 2023 | $14.9B |
| 2022 | $15.0B |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.59B | $3.81B | $2.70B | $2.75B | $2.63B | $2.81B | $2.83B | $2.97B |
| YoY Growth | -1.6% | 2.8% | -27.2% | -29.1% | -26.9% | -26.3% | 5.0% | 8.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $27.79B | $26.31B | $26.68B | $25.78B | $21.30B | $21.05B | $21.07B | $20.05B |
| Liabilities | $19.55B | $18.60B | $18.73B | $18.76B | $14.25B | $13.75B | $13.85B | $13.95B |
| Equity | $8.17B | $7.64B | $7.87B | $6.96B | $7.08B | $7.32B | $7.24B | $6.13B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $163.0M | $115.0M | $253.0M | $488.0M | $-193.0M | $217.0M | $237.0M | $584.0M |
Other Health Care Companies
ABT
Abbott Laboratories
Revenue
$11.4B
Net Profit
$1.6B
BDX
Becton Dickinson
Revenue
$5.3B
Net Profit
$382.0M
BSX
Boston Scientific
Revenue
$5.3B
Net Profit
$670.0M
DXCM
Dexcom
Revenue
$1.3B
Net Profit
$267.3M
EW
Edwards Lifesciences
Revenue
$1.6B
Net Profit
$291.1M
GEHC
GE HealthCare
Revenue
$5.7B
Net Profit
$588.0M
HOLX
Hologic
Revenue
$1.0B
Net Profit
$179.1M
IDXX
Idexx Laboratories
Revenue
$1.1B
Net Profit
$274.6M
PODD
Insulet Corporation
Revenue
$783.7M
Net Profit
$101.6M
ISRG
Intuitive Surgical
Revenue
$2.9B
Net Profit
$794.8M